BioNTech : Joint report of the Management Board of BioNTech SE and the management of BioNTech Individualized mRNA Manufacturing GmbH on the domination and profit and loss transfer agreement pursuant to Sec. 293a of the German Stock Corporation Act

English Convenience Translation - the German language joint report is decisive


Joint report of the Management Board of BioNTech SE, Mainz, and the management of... | April 13, 2023

Related Keywords

Germany ,Bonn ,Nordrhein Westfalen ,German ,Sean Marett ,Martin Lang ,Rudolf Staudigl ,Oliver Hennig ,Jens Holstein ,Helmut Jeggle ,Anja Morawietz ,Christoph Huber ,Ryan Richardson ,Michael Motschmann ,Sierk Poetting ,Ulrich Wandschneider ,Register Local Court ,Biontech Or Controlling Company ,Bonn Local Court ,German Stock Corporation Act Aktiengesetz ,Articles Of Association ,Mainz Local Court ,Register Of The Local Court ,Controlling Company ,Articles Of Association Biontech ,English Convenience Translation ,Management Board ,German Stock Corporation Act ,Annual General Meeting ,Commercial Register ,Local Court ,Chief Executive Officer ,Chief Operating Officer ,Chief Financial Officer ,Chief Business ,Chief Commercial Officer ,Chief Medical Officer ,Chief Strategy Officer ,Supervisory Board ,Commercial Register Local Court ,German Corporate Income Tax Act ,German Trade Tax Act ,Controlled Company ,German Commercial Code ,Biontech Se Stock Exchange ,News ,Information ,Press Release ,English ,Convenience ,Translation ,The ,Language ,Joint ,Report ,Us ,F ,Management ,Board ,Iontech ,End ,Anagement Bntx Us09075v1026 ,